0161-5890
Semimonthly
No
MOL IMMUNOL
1979
250
ENGLAND
http://www.journals.elsevier.com/molecular-immunology/
約2.0個月審稿時間
約62.5%平均錄用比例
3.064影響因子
生化與分子生物學小學科
月期刊平臺服務過的文章錄用時間為1-3個月,依據(jù)20年經(jīng)驗,經(jīng)月期刊專家預審通過后的文章,投稿通過率100%以上!
分子免疫學主要致力于在分子水平上描述免疫學知識的發(fā)表。在這一框架內(nèi)包括了有關細胞成分和過程的分子分析的貢獻,這些成分和過程是細胞參與免疫現(xiàn)象的生理行為的基礎。僅僅描述新的單克隆抗體和/或表位圖的論文將不再被接受,除非它們與對免疫系統(tǒng)的理解有直接關系。在分子免疫學中,各種形式的通訊將如下:研究報告。這些構成了通訊的主要類別。每一份報告都包括對研究問題、實驗方法和結果的詳細和完整描述。它必須提供新的和重要的知識,并載有其他實驗室核查結論所必需的資料。手稿要經(jīng)過專家審稿人的詳細審查,他們的建議是決定出版可接受性的主要因素。經(jīng)區(qū)域編輯委員會同意,作為“小型專題討論會”的研究報告小組也可由客座編輯組織。這些報告也將受到嚴格審查。預期在選定的領域發(fā)表這類邀請的論文組,可促進最近出現(xiàn)的領域的新空缺,并鼓勵個人在這些新領域作出貢獻。簡短的溝通。為了在分子免疫學領域提供及時而有意義的觀察結果的快速傳播,該雜志將以原稿(2或4頁)的攝影復制形式發(fā)表簡短的通訊。這些手稿也將由專家進行評估。
http://ees.elsevier.com/mimm/
Molecular Immunology is primarily devoted to the publication of immunological knowledge which can be delineated at the molecular level. Within this framework are included contributions concerned with the molecular analysis of the cellular components and processes which underlie the physiological behavior of cells involved in immune phenomena. Papers which merely describe new monoclonal antibodies and/or epitope mapping will no longer be accepted unless they have a direct relevance to the understanding of the immune system. The various forms of communications in Molecular Immunology will be as follows: Research Reports. These constitute the major category of communications. Each report consists of a detailed and complete description of the research problem, the experimental approach and the findings. It must provide new and significant knowledge and contain the information essential for verification of conclusions by other laboratories. Manuscripts are subject to detailed scrutiny by expert reviewers whose recommendations are the primary determinants of acceptability for publication. Groups of research reports as 'mini symposia' may also be organized by a Guest Editor, in agreement with the board of Regional Editors. Such reports will also be subject to critical review. It is anticipated that the publication of such invited groups of papers in selected areas may promote new openings in recently emerging fields and encourage individual contributions in these new areas. Short Communications. To provide rapid dissemination of timely and significant observation in molecular immunology, the journal will publish short communications in the form of a photographic reproduction of the original manuscript (2 or 4 pages). These manuscripts will also be evaluated by experts.
快速預審、投刊前指導、專業(yè)學術評審,對文章進行評價;
立即咨詢校對編輯、深度潤色,讓稿件符合學術規(guī)范,格式體例等標準;
立即咨詢適用于語句和結構尚需完善和調(diào)整的中文文章,確保稿件達到要求;
立即咨詢數(shù)據(jù)庫包括:期刊、文章、書籍、會議、預印書、百科全書和摘要等;
立即咨詢讓作者在期刊選擇時避免走彎路,縮短稿件被接收的周期;
立即咨詢根據(jù)目標期刊格式要求對作者文章進行全面的格式修改和調(diào)整;
立即咨詢幫助作者將稿件提交至目標期刊投稿系統(tǒng),降低退稿或拒稿率;
立即咨詢按照您提供的稿件內(nèi)容,指導完成投稿附信(cover letter);
立即咨詢大類學科同領域優(yōu)質期刊 | 大類學科 | 小類學科 | 影響因子 | 分區(qū) | ISSN |
---|---|---|---|---|---|
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER | 醫(yī)學 | 生化與分子生物學 | 6.887 | N/A | 0304-419X |
BIOORGANIC & MEDICINAL CHEMISTRY | 醫(yī)學 | 生化與分子生物學 | 2.802 | 3區(qū) | 0968-0896 |
Chemical Biology & Drug Design | 醫(yī)學 | 生化與分子生物學 | 2.256 | 4區(qū) | 1747-0277 |
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY | 醫(yī)學 | 生化與分子生物學 | 2.697 | N/A | 1532-0456 |
CURRENT DRUG METABOLISM | 醫(yī)學 | 生化與分子生物學 | 2.277 | 3區(qū) | 1389-2002 |
INFECT MED | 醫(yī)學 | 生化與分子生物學 | N/A | 3區(qū) | 0929-8673 |
MED ORAL PATOL ORAL | 醫(yī)學 | 生化與分子生物學 | N/A | N/A | 0957-9672 |
CURRENT PHARMACEUTICAL BIOTECHNOLOGY | 醫(yī)學 | 生化與分子生物學 | 1.516 | N/A | 1389-2010 |
CYTOKINE | 醫(yī)學 | 生化與分子生物學 | 3.078 | 3區(qū) | 1043-4666 |
EXPERIMENTAL AND MOLECULAR MEDICINE | 醫(yī)學 | 生化與分子生物學 | 4.743 | 2區(qū) | 1226-3613 |
發(fā)現(xiàn)心儀選題請?zhí)顔?/b>
獲取發(fā)表周期短、審稿速度快容易錄用的期刊